Transradial Celiac Artery Angiography in Obese Patients: Feasibility and Safety
This study aims to evaluate the feasibility and safety of performing a transradial celiac artery angiography in obese individuals, with the main focus on the success rate of these selective angiographies.
Transradial celiac artery angiography
Body Weight+5
+ Nutrition Disorders
+ Nutritional and Metabolic Diseases
Other Study
Summary
Study start date: February 9, 2018
Actual date on which the first participant was enrolled.This study focuses on obese patients who undergo catheterization at IUCPQ-UL. Research suggests that embolization of the left gastric artery could lead to significant weight loss. However, catheterization using the femoral artery in obese patients can increase the risk of vascular complications and bleeding. The study aims to explore a safer and more effective method by using the radial artery for catheterization, specifically targeting the celiac and left gastric arteries. This is important as it could potentially improve the safety and effectiveness of catheterization procedures for obese patients. The study is designed as a pilot study at the Quebec Heart & Lung Institute. Participants will undergo transradial angiography of the celiac artery and left gastric artery. This procedure involves inserting a small tube into the radial artery in the wrist, guiding it to the celiac artery, and injecting a special dye to make the artery visible on X-ray. The primary goal is to evaluate the feasibility and safety of this approach by measuring the percentage of successful selective angiographies of the celiac artery. The study also aims to observe variations in the anatomy of the celiac artery and the left gastric artery.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.54 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Inclusion Criteria: * Patients undergoing coronary angiography with a BMI \>30 kg/m² will be eligible. Exclusion Criteria: * Kidney disease defined by a glomerular filtration rate less than 60 ml/min/m² according to the Modification of Diet in Renal Disease (MDRD) formula; * Previous gastric or bariatric surgery; * Emergency coronary procedure. Furthermore, the procedure will be cancelled if one of the following criteria are met during the coronary angiography: * Contrast volume \>250 ml; * Radiation dose \>180 Gy.cm² as assessed by the dose area product (DAP).
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.One single intervention group is designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Quebec Heart & Lung Institute (IUCPQ-UL)
Québec, CanadaOpen Quebec Heart & Lung Institute (IUCPQ-UL) in Google Maps